Advanced

Pituitary disease mortality: is it fiction?

Erfurth, Eva Marie LU ; Siesjö, Peter LU and Björk, Thomas LU (2013) In Pituitary 16(3). p.402-412
Abstract
During the last 20 years a tremendous improvement in the care of patients with pituitary tumors and of hypopituitarism has been achieved. If we resolve most of the possible causes of the increased cardiovascular disease and stroke mortality a normal survival is expected in these patients. Recently, a large population based study showed a decline in the risk of non-fatal stroke and of non-fatal cardiac events in GH deficient patients. This improvement was achieved by complete hormone replacement, including long term GH replacement, together with prescription of cardio protective drugs. If we follow the latest achievements in pituitary imaging, surgery techniques, hormone substitutions, cardio protective medications, we would expect a normal... (More)
During the last 20 years a tremendous improvement in the care of patients with pituitary tumors and of hypopituitarism has been achieved. If we resolve most of the possible causes of the increased cardiovascular disease and stroke mortality a normal survival is expected in these patients. Recently, a large population based study showed a decline in the risk of non-fatal stroke and of non-fatal cardiac events in GH deficient patients. This improvement was achieved by complete hormone replacement, including long term GH replacement, together with prescription of cardio protective drugs. If we follow the latest achievements in pituitary imaging, surgery techniques, hormone substitutions, cardio protective medications, we would expect a normal longevity in these patients. This review will focus on; (1) pituitary insufficiencies and hormone substitutions, (2) modes of cranial radiotherapy, and (3) new techniques in the surgery of a pituitary adenoma. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Pituitary
volume
16
issue
3
pages
402 - 412
publisher
Springer
external identifiers
  • wos:000322704500016
  • pmid:23400812
  • scopus:84881375603
ISSN
1573-7403
DOI
10.1007/s11102-013-0469-1
language
English
LU publication?
yes
id
ad49a7b7-1e1e-4f4a-b2f6-791c986a0396 (old id 3559894)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/23400812?dopt=Abstract
date added to LUP
2013-03-04 10:37:44
date last changed
2019-03-13 15:18:18
@article{ad49a7b7-1e1e-4f4a-b2f6-791c986a0396,
  abstract     = {During the last 20 years a tremendous improvement in the care of patients with pituitary tumors and of hypopituitarism has been achieved. If we resolve most of the possible causes of the increased cardiovascular disease and stroke mortality a normal survival is expected in these patients. Recently, a large population based study showed a decline in the risk of non-fatal stroke and of non-fatal cardiac events in GH deficient patients. This improvement was achieved by complete hormone replacement, including long term GH replacement, together with prescription of cardio protective drugs. If we follow the latest achievements in pituitary imaging, surgery techniques, hormone substitutions, cardio protective medications, we would expect a normal longevity in these patients. This review will focus on; (1) pituitary insufficiencies and hormone substitutions, (2) modes of cranial radiotherapy, and (3) new techniques in the surgery of a pituitary adenoma.},
  author       = {Erfurth, Eva Marie and Siesjö, Peter and Björk, Thomas},
  issn         = {1573-7403},
  language     = {eng},
  number       = {3},
  pages        = {402--412},
  publisher    = {Springer},
  series       = {Pituitary},
  title        = {Pituitary disease mortality: is it fiction?},
  url          = {http://dx.doi.org/10.1007/s11102-013-0469-1},
  volume       = {16},
  year         = {2013},
}